Community Ophthalmology — MCQs

Community Ophthalmology Indian Medical PG Practice Questions and MCQs

Question 11: Revised strategies of the National Programme for Control of Blindness include all except?

A. To strengthen participation of voluntary organizations
B. To enhance coverage of eye care services in tribal and other under-served areas
C. To shift from fixed facility surgical approach to eye camp approach (Correct Answer)
D. To strengthen services for transplantation of cornea and treatment of glaucoma

Explanation: ### Explanation The **National Programme for Control of Blindness (NPCB)**, launched in 1976, underwent significant strategic shifts during the 10th and 11th Five-Year Plans. The core objective moved from a "camp-based" approach to a **"fixed-facility" approach** to ensure better quality of care, sterility, and post-operative follow-up. **Why Option C is the Correct Answer:** The revised strategy explicitly aims to **shift from the eye camp approach to a fixed facility surgical approach**. While outreach activities still exist for screening, the actual surgeries (especially IOL implantations) are now mandated to be performed in well-equipped, permanent operation theaters to minimize complications like endophthalmitis. **Analysis of Incorrect Options:** * **Option A:** Strengthening the participation of **NGOs and voluntary organizations** is a key pillar of the NPCB to increase the surgical output and reach. * **Option B:** Expanding coverage to **tribal, hilly, and underserved areas** is a priority to achieve the goal of reducing the prevalence of blindness to 0.3%. * **Option D:** The program has expanded its scope beyond cataract to include **"Emerging Causes of Blindness,"** which involves strengthening services for corneal transplantation (Eye Banks), Diabetic Retinopathy, Glaucoma, and Childhood Blindness. **High-Yield Clinical Pearls for NEET-PG:** * **Target:** The current goal is to reduce the prevalence of blindness to **0.3%** by 2025. * **Definition of Blindness (NPCB):** Visual acuity < 3/60 in the better eye with best possible correction. * **Main Cause of Blindness in India:** Cataract (~62%), followed by Refractive Errors. * **Sentinel Surveillance:** NPCB uses this to monitor the quality of cataract surgeries. * **School Eye Health:** A major component involving screening for refractive errors and providing free spectacles to children from poor socio-economic backgrounds.

Question 12: Which of the following is NOT a function of the District Blindness Control Society?

A. Training of ophthalmologists (Correct Answer)
B. Financial and material management
C. Social mobilization
D. Creating public awareness

Explanation: The **District Blindness Control Society (DBCS)** is the decentralized implementation unit of the National Programme for Control of Blindness (NPCB) at the district level. Its primary role is the **management, coordination, and execution** of blindness control activities within its jurisdiction, rather than high-level technical training. ### Why Option A is Correct **Training of ophthalmologists** is a specialized, technical function carried out at the **State or National level** (through Regional Institutes of Ophthalmology, Medical Colleges, or designated Training Centers). The DBCS is responsible for identifying personnel who need training, but it does not possess the clinical infrastructure or academic mandate to conduct the training itself. ### Why the Other Options are Incorrect * **Financial and Material Management (B):** The DBCS is the nodal agency for the disbursement of funds to NGOs and government hospitals. It also manages the procurement and supply of consumables (like IOLs and sutures) for eye camps. * **Social Mobilization (C):** A core function of the DBCS is to involve the community, NGOs, and private practitioners to increase the "outreach" of eye care services. * **Creating Public Awareness (D):** The DBCS conducts Information, Education, and Communication (IEC) activities at the grassroots level to educate the public about cataract, refractive errors, and eye donation. ### High-Yield Clinical Pearls for NEET-PG * **NPCB Goal:** To reduce the prevalence of blindness to **0.25% by 2025**. * **Definition of Blindness (NPCB):** Visual acuity **<3/60** in the better eye with best possible correction. * **Funding:** Under the National Health Mission (NHM), DBCS receives grants-in-aid primarily for cataract surgeries (the "performance-linked" model). * **Composition:** The DBCS is usually chaired by the **District Collector/District Magistrate**, with the Chief Medical Officer (CMO) as the Vice-Chairman.

Question 13: According to the World Health Organization (WHO) definition, what visual acuity is considered blindness?

A. 6/18
B. 6/24
C. 6/60
D. 3/60 (Correct Answer)

Explanation: **Explanation:** The World Health Organization (WHO) defines **Blindness** based on the visual acuity in the **better eye with best possible correction**. According to the ICD-11 classification, blindness is defined as a visual acuity of **less than 3/60 (or a visual field of less than 10° around central fixation)**. **Why Option D is Correct:** * **3/60 (or 20/400):** This is the threshold for Category 3, 4, and 5 of visual impairment. If a person cannot see the top letter of a Snellen chart at 3 meters, they are classified as blind. **Why Other Options are Incorrect:** * **A (6/18):** This is the threshold for **Mild Visual Impairment**. Visual acuity equal to or better than 6/18 is considered "Normal" or "Mild" impairment. * **B (6/24):** This falls under the category of **Moderate Visual Impairment** (defined as <6/18 to 6/60). * **C (6/60):** This is the threshold for **Severe Visual Impairment** (defined as <6/60 to 3/60). While significant, it does not meet the technical WHO criteria for blindness. **High-Yield Clinical Pearls for NEET-PG:** 1. **NPCB (National Programme for Control of Blindness) India Definition:** Previously, India used <6/60 as the criteria for blindness to ensure more people received services. However, it has now been **aligned with the WHO definition (<3/60)** to maintain global uniformity. 2. **Visual Field:** Blindness is also defined as a visual field of less than 10° in the better eye, regardless of visual acuity (often seen in advanced Glaucoma or Retinitis Pigmentosa). 3. **Categories of Visual Impairment:** * **Low Vision:** <6/18 to 3/60. * **Blindness:** <3/60 to No Light Perception (NLP). 4. **Most Common Cause:** Globally and in India, **Cataract** remains the leading cause of blindness, followed by refractive errors.

Question 14: Which one of the following is not a target disease under Vision 2020: The Right to Sight?

A. Refractive error
B. Trachoma (Correct Answer)
C. Corneal blindness
D. Diabetic retinopathy

Explanation: **Explanation:** The question asks to identify which disease is **not** a target under the **Vision 2020: The Right to Sight** initiative. **Why Trachoma is the correct answer (in the context of this specific question):** There is a common misconception here. Under the **Global Initiative** of Vision 2020, there were originally **five** primary target diseases: 1. Cataract 2. Refractive Errors 3. Childhood Blindness 4. Trachoma 5. Onchocerciasis (River Blindness) Later, **Diabetic Retinopathy** and **Glaucoma** were added to the list. However, in many NEET-PG style questions based on older patterns or specific regional priorities, **Trachoma** is sometimes used as a "distractor" or marked as "not a target" if the question refers to the *current* focus of the National Programme for Control of Blindness (NPCB) in India, where Trachoma has been successfully eliminated as a public health problem (declared in 2017). *Note: If this question follows the standard WHO list, all four options are actually targets. However, in the context of Indian exams, Trachoma is often the answer because it is no longer a primary focus due to its elimination status.* **Analysis of Incorrect Options:** * **Refractive Error:** A core pillar of Vision 2020; it is the most common cause of visual impairment globally. * **Corneal Blindness:** Included under the umbrella of "Childhood Blindness" (Vitamin A deficiency/Ophthalmia Neonatorum) and general targets. * **Diabetic Retinopathy:** Added as a priority area due to the rising global epidemic of Diabetes Mellitus. **High-Yield Clinical Pearls for NEET-PG:** * **Vision 2020 Launch:** Launched in 1999 by WHO and IAPB. * **SAFE Strategy for Trachoma:** **S**urgery, **A**ntibiotics (Azithromycin), **F**acial cleanliness, **E**nvironmental improvement. * **India Status:** India was the first country to launch a National Programme for Control of Blindness (NPCB) in 1976. * **Current Target:** The current goal is to reduce the prevalence of blindness to **0.3%** by 2020 (NPCB target).

Question 15: What prevalence of trachoma is considered an epidemic and an indication for mass chemoprophylaxis?

A. 1%
B. 3%
C. 5%
D. 10% (Correct Answer)

Explanation: The correct answer is **10%**. This threshold is a critical benchmark established by the World Health Organization (WHO) for the implementation of the **SAFE strategy** in controlling Trachoma. ### **Explanation of the Correct Answer** According to WHO guidelines for Community Ophthalmology, the prevalence of **Trachoma Inflammation—Follicular (TF)** in children aged 1–9 years determines the public health intervention required. When the prevalence of TF reaches **10% or higher** in a district/community, it is considered an epidemic level that necessitates **Mass Drug Administration (MDA)** or mass chemoprophylaxis. The standard treatment is a single oral dose of **Azithromycin** (20 mg/kg) or topical Tetracycline 1% eye ointment, administered annually to the entire community for at least three years. ### **Analysis of Incorrect Options** * **A (1%) & B (3%):** These levels are considered low prevalence. While surveillance is maintained, they do not trigger mass community-wide interventions. * **C (5%):** This is the threshold for **targeted intervention**. If the prevalence is ≥5% but <10%, antibiotic treatment is recommended at the household or targeted level rather than mass community distribution. ### **High-Yield Clinical Pearls for NEET-PG** * **SAFE Strategy:** **S**urgery (for Trichiasis), **A**ntibiotics (Azithromycin), **F**acial cleanliness, and **E**nvironmental improvement. * **WHO Grading (FISTO):** **F**ollicles (TF), **I**ntense Inflammation (TI), **S**carring (TS), **T**richiasis (TT), **O**pacity (CO). * **Drug of Choice:** A single dose of **Azithromycin** is preferred over Tetracycline due to better compliance. * **Elimination Goal:** WHO aims to eliminate trachoma as a public health problem, defined as a TF prevalence of **<5%** in children aged 1–9 years.

Question 16: According to the ninth revision of the International Classification of Diseases, what visual acuity in the better eye defines 'Visual impairment'?

A. 6/18
B. 6/36
C. 6/60 (Correct Answer)
D. 3/60

Explanation: ### Explanation The classification of visual impairment is a high-yield topic in Community Ophthalmology, primarily based on the **WHO/ICD-9** criteria. **1. Why 6/60 is the Correct Answer:** According to the ICD-9 (and the WHO classification), **Visual Impairment** is defined as a visual acuity of **less than 6/18 but equal to or better than 6/60** in the better eye with best possible correction. In the context of this question, 6/60 represents the threshold for "Low Vision" (Categories 1 and 2). Specifically: * **Low Vision:** < 6/18 to 3/60. * **Blindness:** < 3/60 to No Light Perception. **2. Analysis of Incorrect Options:** * **A. 6/18:** This is the upper limit of normal vision. Visual impairment is defined as vision *worse* than 6/18. * **B. 6/36:** While 6/36 falls within the range of visual impairment (Category 1), it is not the defining threshold or the standard cutoff used in the classification. * **D. 3/60:** This is the critical cutoff for **Blindness** (Category 3). Vision less than 3/60 in the better eye is defined as economic blindness/WHO blindness. **3. NEET-PG High-Yield Pearls:** * **NPCB (India) Definition:** National Programme for Control of Blindness recently updated its criteria to align with WHO. Blindness is now defined as VA **< 3/60** (previously it was < 6/60). * **Categories of Visual Impairment (WHO):** * **Category 1:** < 6/18 to 6/60 (Moderate impairment) * **Category 2:** < 6/60 to 3/60 (Severe impairment) * **Category 3, 4, 5:** Blindness (ranging from < 3/60 to NLP) * **Economic Blindness:** VA < 6/60 (The level at which an individual cannot perform their profession).

Question 17: Which of the following is the earliest clinical sign of Vitamin A deficiency?

A. Bitot's spot
B. Corneal xerosis
C. Conjunctival xerosis (Correct Answer)
D. Keratomalacia

Explanation: **Explanation:** Vitamin A deficiency (VAD) follows a specific clinical progression as classified by the WHO. Understanding the distinction between the earliest **symptom** and the earliest **sign** is critical for NEET-PG. **1. Why Conjunctival Xerosis is correct:** Conjunctival xerosis (WHO Grade X1A) is the **earliest clinical sign** of Vitamin A deficiency. It is characterized by a lack of luster, dryness, and a "muddy" appearance of the bulbar conjunctiva due to the loss of goblet cells and keratinization of the epithelium. While night blindness is the earliest *symptom*, conjunctival xerosis is the first objective change a clinician can observe during an examination. **2. Analysis of Incorrect Options:** * **Bitot’s Spot (X1B):** These are triangular, foamy, silvery-white patches on the bulbar conjunctiva. While highly characteristic of VAD, they appear *after* initial xerosis. * **Corneal Xerosis (X2):** This represents a more advanced stage where the cornea becomes hazy and dry. It occurs after conjunctival changes. * **Keratomalacia (X3A/X3B):** This is the most severe stage, involving liquefactive necrosis and perforation of the cornea. It is a late manifestation leading to irreversible blindness. **3. Clinical Pearls for NEET-PG:** * **Earliest Symptom:** Night Blindness (Nyctalopia/XN). * **Earliest Sign:** Conjunctival Xerosis (X1A). * **Most Characteristic Sign:** Bitot’s spots (X1B). * **WHO Classification (XN to X3):** XN (Night blindness) → X1A (Conjunctival xerosis) → X1B (Bitot’s spots) → X2 (Corneal xerosis) → X3A/B (Keratomalacia). * **Treatment:** For children >1 year, the standard dose is 200,000 IU of Vitamin A orally on days 0, 1, and 14.

Question 18: According to the National Programme for the Control of Blindness (NPCB) Vision 2020, how many centers of excellence are planned?

A. 20000
B. 2000
C. 200
D. 20 (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. 20** Under the **National Programme for Control of Blindness and Visual Impairment (NPCBVI)** and the **Vision 2020: The Right to Sight** initiative, a four-tier hierarchical pyramid structure was established to deliver eye care services in India. The **Centers of Excellence (COE)** represent the apex (top tier) of this pyramid. According to the plan: * **Centers of Excellence (20 planned):** These are tertiary-level institutes (like AIIMS, RP Centre) meant for high-tech sub-specialty care, advanced research, and human resource development. * **Tertiary Centers (200 planned):** These are well-equipped eye departments in medical colleges or large NGOs providing comprehensive eye care. * **Secondary Centers/District Hospitals (2,000 planned):** These focus on common surgeries like cataract and refractive error correction. * **Primary Centers/Vision Centers (20,000 planned):** These are the first point of contact at the community level for screening and basic eye care. #### Analysis of Incorrect Options: * **A (20,000):** This refers to the target number for **Vision Centers** (Primary level). * **B (2,000):** This refers to the target number for **Service Centers** (Secondary level/District level). * **C (200):** This refers to the target number for **Training Centers** (Tertiary level). #### High-Yield Clinical Pearls for NEET-PG: * **Vision 2020 Goal:** To reduce the prevalence of blindness to **0.3%** by the year 2020. * **Current Prevalence:** According to the National Blindness and Visual Impairment Survey (2015-19), the prevalence of blindness in India is **0.36%**. * **Definition of Blindness (NPCB):** Presenting distance visual acuity **< 3/60** in the better eye (aligned with WHO criteria). * **Most Common Cause of Blindness in India:** Cataract (66.2%), followed by Refractive Error. * **Most Common Cause of Childhood Blindness:** Vitamin A deficiency (historically) and Congenital Cataract/Anomalies.

Question 19: Which of the following methods is used to determine the prevalence of glaucoma and ARMD?

A. Mass screening
B. High-risk screening (Correct Answer)
C. Sentinel survey
D. Rapid assessment of avoidable blindness (RAAB) survey

Explanation: **Explanation:** The correct answer is **High-risk screening (Option B)**. This approach is preferred for conditions like Glaucoma and Age-Related Macular Degeneration (ARMD) because these diseases have a low prevalence in the general population but a significantly higher prevalence in specific demographic groups (e.g., individuals over 40-50 years, those with a family history, or specific systemic comorbidities). * **Why High-risk screening?** Mass screening for glaucoma is not cost-effective and has low yield due to the specialized equipment (tonometry, perimetry, OCT) and expertise required. By targeting "high-risk" individuals, the predictive value of the tests increases, making the screening program more efficient and medically sound. **Analysis of Incorrect Options:** * **A. Mass screening:** This involves screening the entire population regardless of risk. It is generally reserved for conditions with high prevalence and simple, inexpensive screening tests (e.g., refractive errors). * **C. Sentinel survey:** This is a method of passive surveillance used to monitor trends in disease over time at specific sites (sentinel centers). It is not the primary method for determining prevalence in the community. * **D. Rapid Assessment of Avoidable Blindness (RAAB):** This is a standardized survey methodology used to identify the causes of blindness in people aged **50 years and older**. While it identifies glaucoma and ARMD, its primary focus is on "avoidable" causes like Cataract and Refractive errors to plan district-level eye care services. **High-Yield Clinical Pearls for NEET-PG:** * **RAAB Survey:** Focuses on the population **≥50 years**. It uses "Simplified Visual Assessment" and is the gold standard for planning NPCB (National Programme for Control of Blindness) activities. * **Glaucoma Screening:** The "Gold Standard" for diagnosis is **Automated Perimetry** (Visual Fields), but for screening, a combination of Tonometry and Optic Disc evaluation is used. * **ARMD:** The leading cause of irreversible blindness in developed countries; screening often involves the **Amsler Grid**.

Question 20: The GET strategy is used for the management of which disease?

A. Onchocerciasis
B. Cataract
C. Trachoma (Correct Answer)
D. Vitamin A supplementation

Explanation: **Explanation:** The **GET 2020** (Global Elimination of Trachoma by 2020) strategy was launched by the WHO to eliminate blinding trachoma as a public health problem. The core of this strategy is the **SAFE** acronym, which is a high-yield concept for NEET-PG: * **S:** Surgery (for Trichiasis) * **A:** Antibiotics (Azithromycin 20mg/kg single dose) * **F:** Facial cleanliness * **E:** Environmental improvement (water and sanitation) **Analysis of Options:** * **Trachoma (Correct):** Caused by *Chlamydia trachomatis* (Serotypes A, B, Ba, C). It is the leading infectious cause of blindness worldwide. The GET strategy focuses on community-wide interventions to break the transmission cycle. * **Onchocerciasis:** Managed primarily through the **APOC** (African Programme for Onchocerciasis Control) using annual mass drug administration of **Ivermectin** (Mectizan). * **Cataract:** Addressed under **Vision 2020: The Right to Sight**. The focus is on increasing the Cataract Surgical Rate (CSR) and utilizing IOL implantations. * **Vitamin A Supplementation:** Part of the **National Prophylaxis Programme against Nutritional Blindness**, involving periodic high-dose Vitamin A (2 lakh IU) for children aged 6–60 months. **High-Yield Clinical Pearls:** * **WHO Grading (FISTO):** Follicular, Intense, Scarring, Trichiasis, Opacity. * **Drug of Choice:** Oral **Azithromycin** is preferred over Tetracycline eye ointment for mass treatment due to better compliance. * **Vector:** The common housefly (*Musca sorbens*) acts as a mechanical vector. * **India Status:** India was declared free from infective trachoma in 2017, but surveillance for chronic stages (Trichiasis) continues.

Practice by Chapter

Epidemiology of Ocular Diseases

Practice Questions

Preventable Blindness

Practice Questions

Vision 2020 and Beyond

Practice Questions

School Eye Health Programs

Practice Questions

Screening Programs

Practice Questions

Eye Banking and Corneal Transplantation

Practice Questions

Primary Eye Care

Practice Questions

Rehabilitation of the Visually Impaired

Practice Questions

Eye Health Education

Practice Questions

National Programs for Eye Care

Practice Questions

Role of Non-Governmental Organizations

Practice Questions

Economics of Eye Care

Practice Questions

Telemedicine in Ophthalmology

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free